More tools:Markets·Screener·Research·Chat

GLOBUS MEDICAL INC (GMED) Financial Statements

GLOBUS MEDICAL INC
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG002V87T57
XNYS · usd
79.00▲ 3.96 (5.28%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close75.04
Day's Range74.95 – 78.29
52-Week Range54.15 – 101.40
Volume1.9M
Avg Volume1.3M
Share Statistics
Shares Outstanding
Employees6,000
ExchangeXNYS
Listed2012-08-03
Share count as of August 4, 2026
Loading Income Statement…
Key questions about GLOBUS MEDICAL INC (GMED)
What is GLOBUS MEDICAL INC's Market Cap?
GLOBUS MEDICAL INC's Market Cap is $10.6B, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's Enterprise Value?
GLOBUS MEDICAL INC's Enterprise Value is $10.0B, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's Trailing P/E?
GLOBUS MEDICAL INC's Trailing P/E is 19.8×, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's Price / Sales?
GLOBUS MEDICAL INC's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's EV / Revenue?
GLOBUS MEDICAL INC's EV / Revenue is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's EV / EBITDA?
GLOBUS MEDICAL INC's EV / EBITDA is 10.3×, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's Revenue (TTM)?
GLOBUS MEDICAL INC's Revenue (TTM) is $3.1B, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's Net Income (TTM)?
GLOBUS MEDICAL INC's Net Income (TTM) is $535.4M, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's EBITDA?
GLOBUS MEDICAL INC's EBITDA is $919.4M, based on as-reported figures from SEC (XBRL) filings.
What is GLOBUS MEDICAL INC's Diluted EPS (TTM)?
GLOBUS MEDICAL INC's Diluted EPS (TTM) is 3.99, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth+5.9%+27.0%+25.7%+22.9%
Cost of Sales and Operating expenses:
Cost of sales (exclusive of amortization of intangibles)
Research and development
Selling, general and administrative
Amortization of intangibles
Acquisition-related costs
Restructuring costs
Operating income/(loss)
% of revenue23.1%19.8%20.5%17.9%
Other income/(expense), net
Interest income/(expense), net
Foreign currency transaction gain/(loss)
Bargain purchase gain
Other income/(expense)
Total other income/(expense), net
Income/(loss) before income taxes
Income tax provision/(benefit)
Net income/(loss)
% of revenue19.2%16.4%17.0%15.5%
Basic (in USD per share)
Diluted (in USD per share)